National strategies for the reduction and prevention of suicide

Crisis

Volumn 26, Issue 1, 2005, Pages 1-3

  Beautrais, Annette L ^a,b  

^a Canterbury Suicide Project   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; SEROTONIN UPTAKE INHIBITOR;

ALCOHOL INTOXICATION; BEHAVIOR THERAPY; BIPOLAR DISORDER; COGNITIVE THERAPY; COPING BEHAVIOR; COST EFFECTIVENESS ANALYSIS; DETOXIFICATION; EDITORIAL; ELECTROCONVULSIVE THERAPY; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL HEALTH; PREVENTIVE MEDICINE; RISK ASSESSMENT; RISK REDUCTION; SCHIZOPHRENIA; SUICIDE; EVIDENCE BASED MEDICINE; HEALTH CARE PLANNING; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH;

EVIDENCE-BASED MEDICINE; HEALTH PLANNING; HUMANS; NATIONAL HEALTH PROGRAMS; SUICIDE;

EID: 15744378118     PISSN: 02275910     EISSN: None     Source Type: Journal    
DOI: 10.1027/0227-5910.26.1.1     Document Type: Editorial

References (4)

1. Althaus, D., Schmidtke, A. et al. (2003). Preventing suicide by improving the care of patients suffering from depression: Results of the "Nuremberg Alliance Against Depression" (NAD). Paper presented at Crossing Borders in Suicide Prevention - From the Genes to the Human Soul. XXII World Congress of the International Association for Suicide Prevention (IASP), Stockholm, Sweden.
2. Knox, K.L., Litts, D.A. et al. (2003). Risk of suicide and related adverse outcomes after exposure to a suicide prevention programme in the US Air Force: Cohort study. British Medical Journal, 327, 1-5.
3. Mrazek, P.J., & Haggerty, R.J. (1994). Reducing risks for mental disorders. Washington, DC: National Academy Press.
4. Wasserman, D., & Varnik, A. (1998). Suicide-preventive effects of perestroika in the former USSR: The role of alcohol restriction. Acta Psychiatrica Scandinavica 98(Suppl. 394), 1-4.